Alice Bartolini Selected Research

Alice Bartolini Research Topics

16	Neoplasms (Cancer) 01/2024 - 11/2012
15	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 11/2012
3	Neoplasm Metastasis (Metastasis) 01/2017 - 11/2012
3	Neuroblastoma 11/2015 - 09/2013
1	Turcot syndrome 01/2022
1	Disease Progression 01/2020
1	Lymphopenia (Lymphocytopenia) 10/2018
1	Neutropenia 10/2018
1	Sarcoma (Soft Tissue Sarcoma) 10/2018
1	Thrombocytopenia (Thrombopenia) 10/2018
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2017

6	Peptides (Polypeptides)IBA 01/2024 - 11/2012
4	LigandsIBA 11/2015 - 11/2012
3	Proteins (Proteins, Gene)FDA Link 12/2019 - 10/2015
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 12/2016
2	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 12/2017
2	Panitumumab (Vectibix)FDA Link 01/2022 - 12/2016
2	Monoclonal AntibodiesIBA 01/2022 - 12/2016
2	olaparibIBA 01/2020 - 10/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 01/2017
2	Liposomes (Liposome)IBA 11/2015 - 09/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2015 - 09/2013
1	AntigensIBA 01/2024
1	Thioguanine (Tioguanine)FDA Link 01/2023
1	Cancer VaccinesIBA 01/2023
1	Circulating Tumor DNAIBA 01/2022
1	pembrolizumabIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	TrabectedinIBA 10/2018
1	Alanine Transaminase (SGPT)IBA 10/2018
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2018
1	human ERBB2 proteinIBA 01/2017
1	Calcibiotic Root Canal SealerIBA 12/2016
1	Cetuximab (Erbitux)FDA Link 12/2016
1	Small Interfering RNA (siRNA)IBA 04/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	entrectinibIBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 11/2015
1	SuspensionsIBA 11/2015
1	AntibodiesIBA 10/2015
1	PLX 4720IBA 12/2013
1	carfilzomibIBA 12/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2013
1	Proteasome InhibitorsIBA 12/2013
1	IntegrinsIBA 11/2012
1	AngiopoietinsIBA 11/2012
1	Cadherins (E-Cadherin)IBA 11/2012

9	Therapeutics 01/2023 - 09/2013
2	Immunotherapy 01/2024 - 01/2022